NCT03686709Recruiting
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
Source: ClinicalTrials.gov · Last updated 27 Sept 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion of Y90 microspheres for treatment of hepatocellular carcinoma (HCC) and other metastatic liver disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 5 Jul 2018
- Start date
- 19 Jun 2018
- Primary completion date
- 18 Jun 2019
- Lead sponsor
- University of Tennessee
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT03686709
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 19 Jun 2018 to the primary completion date, 18 Jun 2019
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients that are not candidates for Y90 radioembolization therapy
- Patients that cannot tolerate additional imaging procedures following therapy
Other
- Patients that cannot tolerate the additional blood draws required for this study
- Patients whose schedule does not allow them to remain at the hospital for the additional PET/CT imaging study
Who the study is looking for
- All patients undergoing Y90 radioembolization therapy with SIR-Spheres or TheraSpheres are eligible to participate in this study
- Must be able to schedule and tolerate additional PET/CT imaging following therapy
- Must be able to tolerate additional blood draws before, during, and after the radioembolization therapy procedure.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Tennessee Medical Center Coordinator of this site? Confirm its status | Knoxville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.